Grade: Pharmaceutical Grade

Factory Location: Quanzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

Teneligliptin Hydrobromide Hydrate is a dipeptidyl peptidase-4 (DPP-4) inhibitor and is indicated for the treatment of type 2 diabetes. Ticagliptin can inhibit the decomposition of GLP-1 by suppressing the activity of DPP-4, and thereby reduce blood sugar by increasing the concentration of active GLP-1 in the blood.